Dr Julie Ledgerwood, the lead researcher, said: “This is the first study to show comparable safety and immune response of an experimental Ebola vaccine in an African population.
“This is particularly encouraging because those at greatest risk of Ebola live primarily in Africa and diminished vaccine protection in African populations has been seen for other diseases.”
The first African trial of vaccines against Ebola showed a modest immune response and promising safety results according to scientists. Read the article below:
The virus is spread through close contact with infected bodily fluids | Image Source: bbc.com
The first-ever trial of an Ebola vaccine in Africa shows promising initial results, according to a report in the Lancet medical journal.
Scientists say it is a crucial step as other vaccines have shown lower levels of protection in African populations.
Tests involving Ugandan and American volunteers reveal the vaccine is so far safe and generates an immune response in both populations.
It provides reassurance for other trials currently underway, they say.
The Ebola virus has killed more than 6,900 people in the worst-affected countries of Sierra Leone, Liberia and Guinea.
No proven vaccine exists to prevent people from getting the disease, though several trials are underway.
The aim of a…
View original post 214 more words